📰 Nasdaq Amph News
Page 8 - Nasdaq Amph News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Nasdaq Amph. Real-time updates on events, politics, business and more.
April 6, 2022
Shares of Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH – Get Rating) have been given a consensus recommendation of “Hold” by the six research firms that are covering the company, MarketBeat.com reports. One analyst has rated the stock with a sell rating, one has given a hold rating and three have assigned a buy rating to the company. […]
April 6, 2022
Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH – Get Rating) Director Floyd F. Petersen sold 500 shares of the company’s stock in a transaction dated Friday, April 1st. The stock was sold at an average price of $36.69, for a total value of $18,345.00. The sale was disclosed in a document filed with the Securities & Exchange Commission, […]
April 1, 2022
Wall Street analysts predict that Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH – Get Rating) will post $0.42 earnings per share (EPS) for the current fiscal quarter, according to Zacks. Three analysts have made estimates for Amphastar Pharmaceuticals’ earnings. The lowest EPS estimate is $0.33 and the highest is $0.51. Amphastar Pharmaceuticals posted earnings per share of $0.27 […]